Noteworthy, Shvartsur et al. constructed various possible cross-talks between RKIP (active/inactive) and the gene products underlying the mechanism of RKIP overexpression in multiple myeloma, aiming to use such molecular signatures for a more precise diagnosis/prognosis of the disease [80]. The gene discussed is PEBP1; the disease is AL amyloidosis.